DHEA and DHEA-S: A review

Journal of Clinical Pharmacology

Volumn 39, Issue 4, 1999, Pages 327-348

  Kroboth, Patricia D ^a   Salek, Firoozeh S ^b   Pittenger, Amy L ^b   Fabian, Tanya J ^b   Frye, Reginald F ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMLODIPINE; BENFLUOREX; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CORTICOTROPIN; DANAZOL; DEXAMETHASONE; DILTIAZEM; INSULIN; METFORMIN; MORPHINE; NITRENDIPINE; ORAL ANTIDIABETIC AGENT; PRASTERONE; PRASTERONE SULFATE; RETINOL; VALPROIC ACID;

BODY COMPOSITION; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HORMONE BINDING; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; INSULIN SENSITIVITY; MALE; MENTAL DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032948925     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912709922007903     Document Type: Review

References (151)

1. Nieschlag E, Loriaux DL, Ruder HJ, Zucker IR, Kirschner MA, Lipsett MB: The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Clin Endocr 1973;57:123-134.
2. Jaroff L: New age therapy. Time 1995;January 23:52.
3. Perlman D: Puzzling hormone DHEA may slow the signs of aging. Pittsburgh Post-Gazette 1995;January 16.
4. Morales AJ, Nolan JJ, Nelson JC, Yen SSM: Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-1367.
5. Lopez SA: Metabolic and endocrine factors in aging, in: Rothschild H (ed.): Risk Factors for Senility. New York: Oxford University Press, 1984;205-219.
6. Rudman D, Shetty KR, Mattson DE: Plasma dehydroepiandrosterone sulfate in nursing home men. J Am Geriatr Soc 1990;38:421-427.
7. A receptor: mechanism of action and physiological significance. Prog Neurobiol 1992;38:379-395.
8. Mellon SH: Neurosteroids: biochemistry, modes of action, and clinical relevance. J Clin Endocrinol Metab 1994;78:1003-1008.
9. Robel P, Baulieu E-E: Neurosteroids biosynthesis and function. Trends Endocrinol Metab 1994;5:1-8.
10. Regelson W, Loria R, Kalimi M: Dehydroepiandrosterone (DHEA) - the "mother steroid": I. Immunologic action. Ann N Y Acad Sci 1994;719:553-563.
11. Lancaster FE: Gender differences in the brain: implications for the study of human alcoholism. Alcohol Clin Exp Res 1994;18:740-746.
12. SCC in rat brain. Science 1987;237:1212-1215.
13. Flier JS, Foster DW: Eating disorders: obesity, anorexia nervosa, and bulimia nervosa, in: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds.): Williams Textbook of Endocrinology. Philadelphia: W. B. Saunders, 1998;1061-1097.
14. Birkenhager-Gillesse EG, Derksen J, Lagaay AM: Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann N Y Acad Sci 1994;719:543-552.
15. Montanini V, Simoni M, Chiossi G, Baraghini GF, Velardo A, Baraldi E, Marrama P: Age-related changes in plasma dehydroepiandrosterone sulphate, cortisol, testosterone and free testosterone circadian rhythms in adult men. Hormone Res 1988;29:1-6.
16. Labrie F, Bélanger A, Cusan L, Candas B: Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 1997;82:2403-2409.
17. Falany CN: Enzymology of human cytosolic sulfotransferases. FASEB J 1997;11:206-216.
18. Wood TC, Her C, Aksoy I, Otterness DM, Weinshilboum RM: Human dehydroepiandrosterone sulfotransferase pharmacogenetics: quantitative western analysis and gene sequence polymorphisms. J Steroid Biochem Molec Biol 1996;59:467-478.
19. Vermeulen A: Adrenal androgens and aging, in: Genazzani AR, Thijssen JHH, Siiteri PK (eds.): Adrenal Androgens. New York: Raven, 1980;207-217.
20. Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G: Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab 1997;82:2578-2585.
21. Pittenger AL, Amico JA, Fabian TJ, Kroboth FJ, Folan MM, Kroboth PD: DHEA and responses of patients with adrenal insufficiency to single doses of alprazolam. Pharmacother 1998;18:1176.
22. Kishimoto Y, Hoshi M: Dehydroepiandrosterone sulphate in rat brain: incorporation from blood and metabolism in vivo. J Neurochem 1972;19:2207-2215.
23. Bird CH, Masters V, Clark AF: Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin Invest Med 1984;7:119-122.
24. Poortman J, Andriesse R, Agema A, Donker GH, Schwarz F, Thijssen JHH: Adrenal androgen secretion and metabolism in postmenopausal women. in: Genazzani AR, Thijssen JHH, Siiteri PK (eds.): Adrenal Androgens. New York: Raven, 1980;219-240.
25. Labrie F, Bélanger A, Cusan L, Gomez J-L, Candas B: Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396-2402.
26. Labrie C, Flamand M, Bélanger A, Labrie F: High bioavailability of dehydroepiandrosterone administered percutaneously in the rat. J Endocrinol 1996;150:S107-S118.
27. Longcope C: Dehydroepiandrosterone metabolism. J Endocrinol 1996;150:S125-S127.
28. Rosenfeld RS, Rosenberg BJ, Fukushima DK, Hellman L: 24-hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 1975;40:850-855.
29. Rosenfeld RS, Hellman L, Roffwarg H, Weitzman ED, Fukushima DK, Gallagher TF: Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man. J Clin Endocr 1971;33:87-92.
30. Pavlov EP, Harman SM, Chrousos GP, Loriaux DL, Blackman MR: Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986;62:767-772.
31. Parker CR Jr, Azziz R, Potter HD, Boots LR: Adrenal androgen production in response to adrenocorticotropin infusions in men. Endocrine Research 1996;22:717-722.
32. Mooradian AD: Mechanisms of age-related endocrine alterations - part I. Drugs & Aging 1993;3:81-97.
33. Abraham GE: Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 1974;39:340-346.
34. Ohashi M, Kato K, Nawata H, Ibayashi H: Adrenocortical responsiveness to graded ACTH infusions in normal young and elderly human subjects. Gerontology 1986;32:43-51.
35. Hauffa BP, Kaplan SL, Grumbach MM: Dissociation between plasma adrenal androgens and cortisol in Cushing's disease and ectopic ACTH-producing tumor: relation to adrenarche. Lancet 1984;1:1373-1375.
36. Anker SD, Clark AL, Kemp M, Salsbury C, Teixeira MM, Hellewell PG, Coats AJS: Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 1997;30:997-1001.
37. Lephart ED, Baxter CR, Parker CR Jr: Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab 1987;64:842-848.
38. Parker LN, Levin ER, Lifrak ET: Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985;60:947-952.
39. Del Ponte A, Di Monte MG, Graziani D, Guagnano MT, Menduni P, Vitullo F, Sensi S: Changes in plasma DHEAS circadian rhythm in elderly men. Prog Clin Biol Res 1990;341A:791-796.
40. Remer T, Manz F, Pietrzik K: Re-examination of the effect of hCG on plasma levels and renal excretion of dehydroepiandrosterone sulfate in healthy males. Steroids 1995;60:204-209.
41. Osran H, Reist C, Chen C, Lifrak ET, Chicz-Demet A, Parker LN: Adrenal androgens and cortisol in major depression. Am J Psychiatry 1993;150:806-809.
42. Baulieu E-E, Robel P, Vatier O, Haug M, LeGoascogne C, Bourreau E: Neurosteroids: pregnenolone and dehydroepiandrosterone in the brain, in: Fuxe K, Agnati LF (eds.): Receptor-Receptor Interactions. New York: Macmillan, 1987;89-104.
43. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu E-E: Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 1981;78:4704-4707.
44. Robel P, Baulieu E-E: Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann N Y Acad Sci 1995;774:82-110.
45. Lacroix C, Fiet J, Benais J-P, Gueux B, Bonete R, Villette J-M, Gourmel B, Dreux C: Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J Steroid Biochem 1987;28:317-325.
46. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J: Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 1996;81:3951-3960.
47. Goodyer IM, Herbert J, Altham PME, Pearson J, Secher SM, Shiers HM: Adrenal secretion during major depression in 8-to 16-year olds: 1. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychological Medicine 1996;26:245-256.
48. de la Torre B, Hedman M, Nilsson E, Olesen O, Thörner Å: Relationship between blood and joint tissue DHEAS levels in rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 1993;11: 597-601.
49. Mortola JF, Yen SSC: The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990;71:696-704.
50. Sulcová J, Hill M, Hampl R, Stárka L: Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 1997;154:57-62.
51. Carlström K, Brody S, Lunell N-O, Lagrelius A, Möllerström G, Pousette Å, Rannevik G, Stege R, von Schoultz B: Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas 1988;10:297-306.
52. Orentreich N, Brind JL, Rizer RL, Vogelman JH: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-555.
53. Grumbach MM, Styne DM: Puberty: ontogeny, neuroendocrinology, physiology, and disorders, in: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds.): Williams Textbook of Endocrinology. Philadelphia: W. B. Saunders, 1998;1509-1625.
54. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H: Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992;75:1002-1004.
55. Liu CH, Laughlin GA, Fischer UG, Yen SSC: Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990;71:900-906.
56. Schiebinger RJ, Albertson BD, Cassorla FG, Bowyer DW, Geelhoed GW, Cutler GB Jr, Loriaux DL: The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. J Clin Invest 1981;67:1177-1182.
57. Aksoy IA, Sochorová V, Weinshilboum RM: Human liver dehydroepiandrosterone sulfotransferase: nature and extent of individual variation. Clin Pharmacol Ther 1993;54:498-506.
58. Luppa P, Munker R, Nagel D, Weber M, Engelhardt D: Serum androgens in intensive-care patients: correlations with clinical findings. Clin Endocrinol 1991;34:305-310.
59. Wade CE, Lindberg JS, Cockrell JL, Lamiell JM, Hunt MM, Ducey J, Jurney TH: Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metab 1988;67:223-227.
60. Swenson CD, Gottesman SRS, Belsito DV, Samanich KM, Edington J, Thorbecke GJ: Relationship between humoral immunoaugmenting properties of DHEAS and IgD-receptor expression in young and aged mice. Ann N Y Acad Sci 1995;774:249-258.
61. Pittenger AL, Hess M, Stoeffel J, Kroboth PD: DHEA and DHEA-S concentrations and relationship with APACHE scores in patients in an intensive care unit. Unpublished manuscript, University of Pittsburgh, 1996.
62. Diamond P, Brisson GR, Candas B, Peronnet F: Trait anxiety, submaximal physical exercise and blood androgens. Eur J Appl Physiol 1989;58:699-704.
63. Cumming DC, Brunstrung LA, Strich G, Ries AL, Rebar RW: Reproductive hormone increases in response to acute exercise in men. Med Sci Sports Exerc 1997;18:369-373.
64. Milani RV, Lavie CJ, Barbee WB, Littman AB: Lack of effect of exercise training on dehydroepiandrosterone-sulfate. Am J Med Sci 1995;310:242-246.
65. Bernton E, Hoover D, Fein H, Galloway R, Popp K: Adaptation to chronic stress in military trainees: adrenal androgens, testosterone, glucocorticoids, IGF-1 and immune function. Ann N Y Acad Sci 1995;774:217-231.
66. A receptor. Brain Res 1990;526:143-146.
67. Delorey TM, Olsen RW: GABA and glycine, in: Siegel GJ, Agranof BW, Albers RW, Molinoff PB (eds.): Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. New York: Raven, 1994;389-399.
68. Dingledine R, McBain CJ: Excitatory amino acid transmitters, in: Siegel GJ, Agranof BW, Albers RW, Molinoff PB (eds.): Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. New York: Raven, 1994;367-387.
69. A receptor. Neuroscience 1991;45(1):127-135.
70. Majewska MD, Schwartz RD: Prognenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain? Brain Bes 1987;404:355-360.
71. Majewska MD, Mienville J-M, Vicini S: Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett 1988;90:279-284.
72. A receptor complex reveals that it may act via the picrotoxin site. J Pharmacol Exp Ther 1997;282:827-833.
73. Carette B, Poulain P: Excitatory effect of dehydroepiandrosterone, its sulphate ester and pregnenolone sulphate, applied by iontophoresis and pressure, on single neurones in the septo-preoptic area of the guinea pig. Neurosci Lett 1984;45:205-210.
74. 3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. J Endocrinol 1996;150:S33-S42.
75. Tordjman S, Anderson GM, McBride PA, Hertzig ME, Snow ME, Hall LM, Ferrari P, Cohen DJ: Plasma adrogens in autism. Journal of Autism and Developmental Disorders 1995;25:295-304.
76. Herbert J, Goodyer IM, Altham PME, Pearson J, Secher SM, Shiers HM: Adrenal secretion and major depression in 8-to 16-year-olds: II. Influence of co-morbidity at presentation. Psychological Medicine 1996;26:257-263.
77. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H: Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 1997;41:311-318.
78. Barrett-Connor E, Friedlander NJ, Khaw K-T: Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res 1990;50:6571-6574.
79. Zumoff B, Walsh BT, Katz JL, Levin J, Rosenfeld RS, Kream J, Weiner H: Subnormal plasma dehydroisoandrosterone to cortisol ratio in anorexia nervosa: a second hormonal parameter of ontogenic regression. J Clin Endocrinol Metab 1983;56:668-672.
80. Cawood EHH, Bancroft J: Steroid hormones, the menopause, sexuality and well-being of women. Psychological Medicine 1996;26:925-936.
81. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendorfer RA, Pirke K-M, Kirschbaum C: Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82:2363-2367.
82. Flood JF, Morely JE, Roberts E: Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci 1992;89:1567-1571.
83. Flood JF, Smith GE, Roberts E: Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 1988;447:269-278.
84. Diamond DM, Branch BJ, Fleshner M, Rose GM: Effects of dehydroepiandrosterone sulfate and stress on hippocampal electrophysiological plasticity. Ann N Y Acad Sci 1995;774:304-307.
85. Wolf OT, Koster B, Kirschbaum C, Pietrowsky R, Kern W, Hellhammer DH, Born J, Fehm HL: A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol Psychiatry 1997;42:845-848.
86. Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F: DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 1995;268:E107-E113.
87. Dyner TS, Lang W, Geaga J, Golub A, Stiles D, Winger E, Galmarini M, Masterson J, Jacobson MA: An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J Acquir Immune Defic Syndr 1993;6:459-465.
88. Jakubowicz DJ, Beer NA, Beer RM, Nestler JE: Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. J Clin Endocrinol Metab 1995;80:3373-3376.
89. Porter JR, Svec F: DHEA diminishes fat food intake in lean and obese Zucker rats. Ann N Y Acad Sci 1995;774:329-331.
90. Svec F, Porter JR: Synergistic anorectic effect of dehydroepiandrosterone and fenfluramine on Zucker rat food intake and selection: the obesity research program. Ann N Y Acad Sci 1995;774:332-334.
91. Wright BE, Abadie J, Svec F, Porter JR: Does taste aversion play a role in the effect of dehydroepiandrosterone in Zucker rats? Physiol Behav 1994;55:225-229.
92. Abadie JM, Wright B, Correa G, Browne ES, Porter JR, Svec F: Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat: the obesity research program. Diabetes 1993;42:662-669.
93. Wright BE, Browne ES, Svec F, Porter JR: Divergent effect of dehydroepiandrosterone on energy intakes of Zucker rats. Physiol Behav 1993;53:39-43.
94. Nestler JE, Barlascini CO, Clore JN, Blackard WG: Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988;66:57-61.
95. Diamond P, Cusan L, Gomez J-L, Bélanger A, Labrie F: Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 1996;150:S43-S50.
96. Welle S, Jozefowicz R, Statt M: Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab 1990;71:1259-1264.
97. Nestler JE, Kahwash Z: Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans. J Clin Invest 1994;94:1484-1489.
98. Lavallee B, Provost PR, Kahwash Z, Nestler JE, Bélanger A: Effect of insulin on serum levels of DHEA metabolites in men. Clin Endocrinol 1997;46:93-100.
99. Nestler JE: Regulation of human dehydroepiandrosterone metabolism by insulin. Ann N Y Acad Sci 1995;774:73-81.
100. Nestler JE, Beer NA, Jakubowicz DJ, Beer RM: Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. J Clin Endocrinol Metab 1994;78:549-554.
101. Nestler JE, Beer NA, Jakubowicz DJ, Colombo C, Beer RM: Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men. J Clin Endocrinol Metab 1995;80:700-706.
102. Beer NA, Jakubowicz DJ, Beer RM, Nestler JE: The calcium channel blocker amlodipine raises serum dehydroepiandrosterone sulfate and androstenedione, but lowers serum cortisol, in insulin-resistant obese and hypertensive men. J Clin Endocrinol Metab 1993;76:1464-1469.
103. Beer NA, Jakubowicz DJ, Beer RM, Arocha IR, Nestler JE: Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men. J Clin Endocrinol Metab 1993;76:178-183.
104. Beer NA, Jakubowicz DJ, Beer RM, Nestler JE: Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. J Clin Endocrinol Metab 1994;79:1077-1081.
105. Bates GW Jr, Egerman RS, Umstot ES, Buster JE, Casson PR: Dehydroepiandrosterone attenuates study-induced declines in insulin sensitivity in postmenopausal women. Ann N Y Acad Sci 1995;774:291-293.
106. H2 immune response. Ann N Y Acad Sci 1995;774:323-325.
107. Watson RR, Huls A, Araghinikuam M, Chung S: Dehydroepiandrosterone and diseases of aging. Drugs & Aging 1996;9:274-291.
108. James K, Premchard N, Skibinska A, Skibinski G, Nicol M, Mason JI: IL-6, DHEA and the ageing process. Mechanisms of Aging and Development 1997;93:15-24.
109. Spencer NFL, Norton SD, Harrison LL, Li G-Z, Daynes RA: Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 1996;31:393-408.
110. Araneo BA, Woods ML II, Daynes RA: Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides and adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 1993;167:830-840.
111. Daynes RA, Araneo BA: The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo. Ann N Y Acad Sci 1994;730:144-161.
112. Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Firedman G: Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine 1995;13:1445-1448.
113. Casson PR, Andersen RN, Herrod HG, Stentz FB, Straughn AB, Abraham GE, Buster JE: Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 1993;169:1536-1539.
114. Khorram O, Vu L, Yen SSC: Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol 1997;52A:M1-M7.
115. Araneo B, Dowell T, Woods ML, Daynes R, Judd M, Evans T: DHEAS as an effective vaccine adjuvant in elderly humans: proof-of-principle studies. Ann N Y Acad Sci 1995;774:232-248.
116. Degelau MD, Guay D, Hallgren H: The effect of DHEAS on influenza vaccination in aging adults. J Am Geriatr Soc 1997;45:747-751.
117. Danenberg HD, Ben-Yehuda A, Zakay-Rones Z, Gross DJ, Friedman G: Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J Clin Endocrinol Metab 1997;82:2911-2914.
118. Christeff N, Lortholary O, Casassus P, Thobie N, Veyssier P, Torri O, Guillevin L, Nunez EA: Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected men. Exp Clin Endocrinol Diabetes 1996;104:130-136.
119. Centurelli MA, Abate MA: The role of dehydroepiandrosterone in AIDS. Ann Pharmacother 1997;31:639-642.
120. Hedman M, Nilsson E, de la Torre B: Low sulpho-conjugated steroid hormone levels in systemic lupus erythematosus (SLE). Clin Exp Rheumatol 1989;7:583-588.
121. Suzuki T, Suzuki N, Engleman EG, Mizushima Y, Sakane T: Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1995;99:251-255.
122. Straub RH, Zeuner M, Antoniou E, Schmolmerich J, Lang B: Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus. J Rheumatol 1996;23:856-861.
123. van Vollenhoven RF, Engleman EG, McGuire JL: Dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rhem 1995;38:1826-1831.
124. Masi AT: Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? Clin Exp Rheumatol 1995;13:227-240.
125. Mirone L, Altomonte L, D'Agostino P, Zoli A, Barini A, Magaro M: A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis: correlation with disease activity. Clin Rheumatol 1996;15:15-19.
126. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Roig-Escofet D: Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 1995;22:1455-1460.
127. Herrington DM, Gordon GB, Achuff SC, Trejo JF, Weisman HJ, Kwiterovich PO, Pearson TA: Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol 1990;16:862-870.
128. Barrett-Connor E, Khaw K-T: Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women. New Engl J Med 1987;317:711.
129. Alexandersen P, Haarbo J, Christiansen C: The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1997;125:1-13.
130. Casson PR, Straughn AB, Umstot ES, Abraham GE, Carson SA, Buster JE: Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration. Am J Obstet Gynecol 1996;174:649-653.
131. Buster JE, Casson PR, Straughn AB, Dale D, Umstot ES, Chiamori N, Abraham GE: Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies. Am J Obstet Gynecol 1992;166:1163-1170.
132. Wittert GA, Stewart DE, Graves MP, Ellis MJ, Evans MJ, Wells JE, Donald RA, Espiner EA: Plasma corticotrophin releasing factor and vasopressin responses to exercise in normal man. Clin Endocrinol 1991;35:311-317.
133. Kroboth PD, Frye RF, Linares AM, Folan MM, Hakala C, Stone RA, Kroboth FJ: Gender differences in pharmacokinetics of DHEA and DHEA-S following single and multiple dose administration of DHEA in healthy older adults. J Neurosci 1998;24;345.
134. Zumoff B, Walter L, Rosenfeld RS, Strain JJ, Degen K, Strain GW, Levin J, Fukushima D: Subnormal plasma adrenal androgen levels in men with uremia. J Clin Endocrinol Metab 1980;51:801-805.
135. Floreani A, Titta M, Plebani M, Faggian D, Chiaramonte M, Naccarato R: Sex hormone changes in post-menopausal women with primary biliary cirrhosis (PBC) and with cryptogenic chronic liver disease. Clin Exp Obstet Gynecol 1991;18:229-234.
136. Yamauchi A, Takei I, Kasuga A, Kitamura Y, Ohashi N, Nakano S, Takayama S, Nakamoto S, Katsukawa F, Saruta T: Depression of dehydroepiandrosterone in Japanese diabetic men-comparison between non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Eur J Endocrinol 1996;135:101-104.
137. Oades RD, Schepker R: Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinol 1994;19:373-385.
138. de la Torre B, Fransson J, Scheynius A: Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis. Clin Exp Rheumatol 1995;13:345-348.
139. Tourney G, Erb JL: Temporal variations in androgens and stress hormones in control and schizophrenic subjects. Biol Psychiatry 1979;14:395-404.
140. Erb JL, Kadane JB, Tourney G, Mickelsen R, Trader D, Szabo R, Davis V: Discrimination between schizophrenic and control subjects by means of plasma dehydroepiandrosterone measurements. J Clin Endocrinol Metab 1981;52:181-186.
141. Svec F, Shawar A-L: The acute effect of a noontime meal on the serum levels of cortisol and DHEA in lean and obese women. Psychoneuroendocrinol 1997;22:S115-S119.
142. Khaw K-T, Chir MBB, Tazuke S, Barrett-Connor E: Cigarette smoking and levels of adrenal androgens in postmenopausal women. New Engl J Med 1988;318:1705-1709.
143. Salvini S, Stampfer MJ, Barbieri RL, Hennekens CH: Effects of age, smoking and vitamins on plasma DHEAS levels: a cross-sectional study in men. J Clin Endocrinol Metab 1992;74:139-143.
144. Field AE, Graham CA, Willett WC, Longcope C, McKinlay JB: The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994;79: 1310-1316.
145. Kroboth PD, Salek FS, Stone RA, Bertz RJ, Kroboth FJ: Alprazolam increases DHEA concentrations in young and elderly men. J Clin Psychopharmacol 1998;19.
146. Santen RJ, Samojlik E, Lipton A, Harvey H, Ruby EB, Wells SA, Kendall J: Kinetic, hormonal, and clinical studies with aminoglutethimide in breast cancer. Cancer 1977;39:2948-2958.
147. Geisler J, Engelsen BA, Berntsen H, Geisler S, Lonning PE: Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients. J Endocrinol 1997;153:307-312.
148. Murakami K, Nakagawa T, Yamashiro G, Araki K, Akasofu K: Adrenal steroids in serum during danazol therapy, taking into account cross-reactions between danazol metabolites and serum androgens. Endocrine Journal 1993;40:659-664.
149. Parker LN, Odell WD: Control of adrenal androgen secretion. Endocrine Review 1980;1:392-410.
150. Crave J-C, Fimbel S, Lejeune H, Cugnardey N, Cechaud H, Pugeat M: Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995;80:2057-2062.
151. Carpenter GW, Garza HH Jr, Gebhardt BM, Carr DJJ: Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen. Brain, Behavior, and Immunity 1994;8:185-203.